Process for preparing recombinant eglin, protease inhibitor

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 6342373
SERIAL NO

07707265

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

The invention relates to DNA sequences which code an eglin, expression plasmids containing such DNA sequences, hosts transformed with such expression plasmids, novel eglin compounds produced from such transformed hosts, monoclonal antibodies against eglins, hybridoma cells which produce such antibodies, and test kits for immunoassays containing such antibodies, and furthermore the processes for their preparation and a process for the preparation of eglins with the aid of the transformed hosts. The eglins which can be prepared according to the invention have useful pharmacological properties.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
UCP GEN-PHARMA AGTALSTRASSE 82 CH-4001 ZURICH

International Classification(s)

  • [Classification Symbol]
  • [Patents Count]

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Alkan, Sefik Reihen, CH 16 226
Fritz, Hans Hohenbrunn, DE 27 224
Liersch, Manfred Riehen, CH 6 15
Marki, Walter Mohlin, CH 8 36
Meyer, Francois Zurich, CH 11 193
Rink, Hans Riehen, CH 17 213
Rittel, Werner Arlesheim, CH 3 36
Seemuller, Ursula Munchen, DE 8 102
Sieber, Peter Reinach, CH 19 376

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation